Patents by Inventor Bernard J. Banks

Bernard J. Banks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020037903
    Abstract: Compounds of formula I, 1
    Type: Application
    Filed: February 8, 2001
    Publication date: March 28, 2002
    Inventors: Bernard J. Banks, Stephen P. Gibson
  • Patent number: 5556868
    Abstract: Avermectin and milbemycin derivatives of formula (I) ##STR1## having a double bond at the 3-4 position and a cyano substituent at the 3-position have outstanding anthelmintic properties. They may be prepared by allowing an avermectin or milbemycin derivative having a leaving group at the 5-position, or having double bonds at the 2-3 and 4-5 positions and no substituent at the 5-position, to react with an ionic cyanide.
    Type: Grant
    Filed: September 28, 1994
    Date of Patent: September 17, 1996
    Assignee: Pfizer Inc
    Inventor: Bernard J. Banks
  • Patent number: 5538990
    Abstract: This invention is directed to anthelmintic benzimidazole compounds of the formula (I), ##STR1## wherein R.sup.1 is C.sub.1 -C.sub.6 alkylthio; R.sup.2 is C.sub.1 -C.sub.4 alkyl; and R.sup.3 is C.sub.1 -C.sub.4 alkyl.
    Type: Grant
    Filed: January 14, 1994
    Date of Patent: July 23, 1996
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Christopher J. Dutton, Alexander C. Goudie
  • Patent number: 5521204
    Abstract: This invention is directed to certain 2-(alkoxycarbonylamino)- and 2-(alkoxycarbonylimino)benzlmidazole derivatives which are useful in the topical, oral or parenteral treatment of animals suffering from helminth infections.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 28, 1996
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Christopher J. Dutton, Alexander C. Goudie
  • Patent number: 5475005
    Abstract: Benzimidazole anthelmintic agents of the formula (I) and their non-toxic salts, wherein R.sup.1, which is in the 5(6)-position, is either H or certain stated substituents, "alk" is a methylene or ethylene group; R.sup.2 is cyano, C.sub.1 -C.sub.4 alkenyl, C.sub.2 -C.sub.4 alkynyl, C.sub.2 -C.sub.4 alkanoyl, C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.4 alkenoxy, aryl, heteroaryl, aryl-(C.sub.1 -C.sub.4 alkoxy) or heteroaryl-(C.sub.1 -C.sub.4 alkoxy), in which "aryl" means phenyl optionally substituted by 1 to 3 substituents each independently selected from halo, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylsulphinyl, and C.sub.1 C.sub.4 alkylsulphonyl in which "heteroaryl" means thienyl, furyl or pyridininyl all optionally substituted by 1 to 3 substituents each independently selected from halo, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylsulphinyl and C.sub.1 -C.sub.4 alkylsulphonyl; and R.sub.3 is a C.
    Type: Grant
    Filed: May 9, 1994
    Date of Patent: December 12, 1995
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Christopher J. Dutton, Alexander C. Goudie
  • Patent number: 5468765
    Type: Grant
    Filed: December 23, 1994
    Date of Patent: November 21, 1995
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Christopher J. Dutton, Alexander C. Goudie
  • Patent number: 5459155
    Abstract: This invention is directed to anthelmintic benzimidazole compounds of formula (IA) or (IB) ##STR1## or non-toxic salts thereof, wherein R, which in the compounds (IA) is in the 5- or 6- position, is H, benzoyl, styryl, phenyloxy, phenylthio, phenylsulfinyl, phenylsulfonyl, phenylsulfonyloxy, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkylthio, C.sub.1 -C.sub.6 alkylsulfinyl, C.sub.1 -C.sub.6 alkylsulfonyl or (C.sub.3 -C.sub.7 cycloalkyl) carbonyl, said phenyl groups, and the phenyl portion of said benzoyl group, optionally having 1 to 3 substituents each independently selected from halo, C.sub.1 -C.sub.4 alkyl, halo-(C.sub.1 -C.sub.4 alkyl), C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylsulfinyl, C.sub.1 -C.sub.4 alkylsulfonyl, C.sub.2 -C.sub.4 alkanoyl, nitro, isothiocyanato, and cyano; and either (a) R.sup.1 is a 1- (C.sub.2 -C.sub.6 alkanoyloxy) (C.sub.1 -C.sub.4 alkyl) group and R.sup.2 is H, C.sub.1 -C.sub.4 alkyl or a 1-(C.sub.1 -C.sub.
    Type: Grant
    Filed: January 14, 1994
    Date of Patent: October 17, 1995
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Christopher J. Dutton, Alexander C. Goudie
  • Patent number: 4992424
    Abstract: Broad spectrum antiparasitic agents of formula (I) having utility as anthelmintics, ectoparasiticides, insecticides, acaricides and animal growth promotants ##STR1## wherein Y is a single bond or a double bond; R.sup.1 is OH; provided that when Y is a single bond R.sup.1 is present and when Y is a double bond R.sup.1 is absent; R.sup.2 is .dbd.CH.sub.2 or a group of the formula --(X)--C(R.sup.5).dbd.CHR.sup.6 ; R.sup.3 is H or CH.sub.3 ; R.sup.5 and R.sup.6 are both H; R.sup.5 is H and R.sup.6 is C.sub.1 -C.sub.3 alkyl; or one of R.sup.5 and R.sup.6 is H and the other is C.sub.2 -C.sub.6 alkoxycarbonyl, phenyl, substituted phenyl, heteroaryl or substituted heteroaryl; and X is a direct bond or an alkylene group having from 2 to 6 carbon atoms which may be straight or branched-chain; with the proviso that R.sup.5 and R.sup.6 are not both hydrogen when X is --CH(CH.sub.3)CH.sub.2 --; processes and intermediates therefor, and compositions thereof.
    Type: Grant
    Filed: March 7, 1989
    Date of Patent: February 12, 1991
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Michael J. Witty
  • Patent number: 4927918
    Abstract: Antiparasitics comprising Avermectin derivatives of formula (I): ##STR1## wherein X represents a single or a double bond; R.sup.1 is H or OH; provided that when X is a single bond, R.sup.1 is H or OH, and when X is a double bond, R.sup.1 is absent;R.sup.2 is an alkyl group substituted by one oxo or one or more hydroxy groups or by a single oxygen atom on two adjacent carbon atoms to form an oxirane ring, or R.sup.2 is an alkyl group substituted by an alkoxycarbonyl group, said substituents on R.sub.2 being attached to either or both a terminal carbon atom and a carbon atom adjacent to a terminal carbon atom of R.sup.2 ; and R.sup.3 is H or CH.sub.3 ; or, when R.sup.2 is oxo-substituted alkyl, an alkyl acetal or ketal derivative thereof.
    Type: Grant
    Filed: April 11, 1989
    Date of Patent: May 22, 1990
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Michael J. Witty
  • Patent number: 4489083
    Abstract: A series of bicyclic imidazole and imidazoline derivatives, including their non-toxic acid addition salts, are disclosed. These particular compounds are useful for combatting ectoparasite and helminth infestations in animals, especially sheep and cattle. 2-(2,3-Dimethylphenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole represents a typical and preferred member compound. Methods for preparing all these compounds from known starting materials are provided.
    Type: Grant
    Filed: November 18, 1982
    Date of Patent: December 18, 1984
    Assignee: Pfizer Inc.
    Inventors: Bernard J. Banks, Alexander B. Penrose